The CD46 gene helps protect your own cells from complement, a group of immune proteins that helps fight germs. If the CD46 gene does not work properly, this system can damage healthy tissue and may contribute to atypical hemolytic uremic syndrome, a rare kidney and blood condition. In medicine, this gene is important because it helps regulate immune balance on cell surfaces. CD46 is not a celebrity gene, but it is well known in kidney and immune genetics.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for making proteins, the parts of cells that do the work. Other genes mainly direct when, where, and how strongly certain processes happen. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To look into this topic more closely, you can find more in the LearnHub.
Overview
CD46Gene function
What if the gene works
The CD46 gene helps make a surface protein that protects your cells from complement, an immune defense system. It also supports how some immune cells respond and communicate.
Risk
What if the gene does not work
CD46 gene variants can reduce control of the complement system and are a well-known cause of atypical hemolytic uremic syndrome, which can injure small blood vessels and kidneys. Milder to more severe variants may affect onset and severity.
Treatment
What does that mean for your treatment
For pathogenic variants in the CD46 gene linked to complement mediated atypical hemolytic uremic syndrome, treatment often centers on complement C5 inhibitors such as eculizumab or ravulizumab. Isolated CD46 variants are also linked to a lower risk of recurrence after kidney transplant than some other complement gene variants, which can shape transplant planning and follow up.
Conditions associated with CD46
Gene function
What if the gene works
Your immune system needs ways to target germs without injuring your own tissues. The CD46 gene gives cells instructions for a surface protein that helps keep that balance. Understanding CD46 gene function helps explain how healthy cells stay protected during normal immune activity.
CD46 sits on the surface of many cells and helps mark them as part of you. This lowers the chance that routine immune activity will damage healthy tissue.
The CD46 protein helps limit complement activity, part of the body's built in immune defense, on the cell surface. It works with factor I, a blood protein, to quiet C3b and C4b, which are immune tags that can trigger attack.
By damping extra complement activity, CD46 helps the immune response stay more controlled. This supports everyday tissue protection while your body continues to recognize and respond to microbes.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CD46 gene can change how much CD46 protein reaches the cell surface or how well it binds immune proteins that need to be switched off, which helps explain how CD46 gene variants affect protein function. Some variants cause a shortened or unstable protein that is cleared away early, while others leave some activity intact. Milder variants may partly preserve function, but more severe variants can leave very little working protein and are more often linked to earlier or stronger complement-driven kidney disease, including atypical hemolytic uremic syndrome.
How variants are linked to conditions
Pathogenic variants in the CD46 gene are most strongly linked to atypical hemolytic uremic syndrome, an uncommon condition that affects the blood and kidneys. In people with CD46 gene variants linked to atypical hemolytic uremic syndrome, the change can raise the chance of disease, but it does not mean symptoms will always develop.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human and are widely found across the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, especially when several genes and environmental influences play a role. In some situations, though, a single well described variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful change in the CD46 gene, risk is often shaped by other factors rather than by CD46 alone. Episodes are more likely to be triggered by things that stress the body, such as infections, pregnancy, some medicines, or major surgery. Family history and changes in other complement genes can also raise risk.
Inheritance of CD46 variants
How CD46 gene variants are inherited depends on the condition they are linked to. For CD46-related atypical hemolytic uremic syndrome, the usual pattern is autosomal dominant with reduced penetrance, so a parent carrying a variant can pass it to a child with a 50% chance, but not everyone who inherits it develops the condition. Some CD46-related conditions follow an autosomal recessive pattern instead, which means a child inherits one altered copy from each parent. CD46 is on chromosome 1, so these variants are inherited similarly in males and females.
What does my CD46 result mean for my family?
For CD46, what this means for family members depends on the specific condition linked to the result. Some CD46-related conditions can run in families in a dominant pattern, so close relatives may also carry the same change, while others are recessive, meaning parents may be healthy carriers and brothers or sisters could also be affected or be carriers. Because of that, the family impact is tied to the exact CD46 result and diagnosis.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CD46 gene, a lab can do genetic testing for CD46 variants on a blood or saliva sample. The lab reads the gene’s DNA code and compares it with a reference sequence to look for variants. Results may show a benign, disease linked, or uncertain variant.
When should I consider getting a genetic test?
Consider CD46 genetic testing if you or a close relative has had a rare blood-and-kidney condition called atypical hemolytic uremic syndrome. Testing can show whether an inherited CD46 change is involved and whether other family members may also carry it.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it reveals depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic variation affects a person’s response to medicines. By studying links between genes and medications, it helps explain why the same treatment can have different effects in different people. With many drugs, genes can influence both how powerfully the medicine works and how the body handles it. Understanding this can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CD46 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects someone may have. Questions about your health, treatment choices, or possible medication side effects are best discussed with your doctor or pharmacist.
History
Researchers first identified the CD46 gene through work on a surface protein once called membrane cofactor protein in the growing field of complement research. In the 1990s, the gene drew broader attention when scientists showed that several microbes, including measles virus, could attach to CD46 to enter human cells. From these first observations, research expanded steadily. Later studies connected CD46 to inherited forms of atypical hemolytic uremic syndrome, helping place it firmly in clinical genetics. The CD46 gene also became important in reproductive biology after researchers found a distinct role for CD46 on sperm cells. Over time, this history made CD46 a well known example of one gene linking immunity, infection research, and inherited disease.